Aquaculture expert and Doctor of Veterinary Medicine, Bawanta Widya Suta has joined Aker BioMarine as Aquaculture Sales Manager in the Animal Health and Nutrition department. Therefore, Wanta will be charged to lead Aker BioMarine's growth journey in Indonesia.
"With Wanta on board, we are taking another step towards growth in Indonesia. His vast experience within the food, agriculture and aquaculture industries in Indonesia will help solidify our strong position. Enabling us to bring greater knowledge, awareness, and interest in krill as a functional ingredient for aquaculture feeds across the region," said Bjørn Wallentin, SVP AQUA Sales, Aker BioMarine.
For instance, Aker BioMarine is actively building its presence in Indonesia. In late 2021, the company announced a strategic partnership with Seven Stones Indonesia to support its market entry.
Indonesia is a high potential aquaculture market, with strong demand both domestically and internationally. Currently, it is estimated to be among the top four countries in terms of shrimp production in the world.
To clarify, as a science-based company, the Aker BioMarine team depends on extensive research to understand the full potential of this tiny crustacean. Also, to ensure the well-being of the krill biomass. The company brings this sustainable approach to Indonesia, with the aim to spread the health benefits of krill across the country's aquaculture industry.
"For me, joining Aker BioMarine was an easy choice. I believe in the potential of krill as a natural source of protein and omega-3. Key sources of nutrition will play an important role as we face food challenges in the future. There is immense opportunity in Indonesia. I believe that aquaculture here can benefit from this more sustainable, functional ingredient. Bringing greater efficiency and profitability with less environmental impact to the producers here," said Bawanta Widya Suta, Aquaculture Sales Manager, Animal Health and Nutrition, Aker BioMarine.
Wanta comes to Aker BioMarine from the Food and Agriculture Organization (FAO), where he focused on farmer training and biosecurity. In addition, he has previously served in leadership and managerial roles in PT. MJPF Farma Indonesia, Biowistechnologies, Inc., and Cargill Aqua Nutrition. He holds a doctorate degree in Veterinary Medicine from Bogor Agriculture University in Indonesia.
QRILL Aqua's key market differentiator is that it improves fish health and performance. In aqua diets, QRILL™ Aqua functions as a feeding stimulant leading to increased feed uptake and enhanced growth. QRILL™ Aqua improves growth performance, health, fillet quality and stress and disease resistance of fish.
Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Listed on Oslo Stock Exchange, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba®, NKO® and K·REAL®), aquaculture (QRILL™ Aqua), and animal feed applications (QRILL™ Pet), including INVI™, a highly concentrated protein isolate, and LYSOVETA™, a targeted transporter of EPA and DHA from krill.
Aker BioMarine's fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. The company's strong focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.